Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Tocilizumab in Primary Sjögren's Syndrome. (ETAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01782235
Recruitment Status : Completed
First Posted : February 1, 2013
Last Update Posted : August 21, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 16, 2018
Actual Study Completion Date : July 16, 2018